Functional Analysis of the Human Papillomavirus Type 16 E1∧E4 Protein Provides a Mechanism for in Vivo and in Vitro Keratin Filament Reorganization

Journal of Virology

Volumn 78, Issue 2, 2004, Pages 821-833

  Wang, Qian ^a   Griffin, Heather ^b   Southern, Shirley ^a   Jackson, Deborah ^a   Martin, Ana ^a   McIntosh, Pauline ^a   Davy, Clare ^a   Masterson, Phillip J ^a   Walker, Philip A ^a   Laskey, Peter ^a   Omary, M Bishr ^c   Doorbar, John ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b MRC CENTRE FOR PROTEIN ENGINEERING   (United Kingdom)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; GREEN FLUORESCENT PROTEIN; HUMAN PAPILLOMAVIRUS 16 E1 PROTEIN; HUMAN PAPILLOMAVIRUS 16 E4 PROTEIN; INTERMEDIATE FILAMENT PROTEIN; KERATIN; KERATIN 18; MONOMER; MUTANT PROTEIN; SERINE; UNCLASSIFIED DRUG; VIMENTIN; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CANCER GRADING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CROSS LINKING; CYTOPLASM; DELETION MUTANT; EPITHELIUM CELL; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; INTERMEDIATE FILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SOLUBILIZATION; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CULTURE TECHNIQUES; CYTOSKELETON; FEMALE; HUMANS; INTERMEDIATE FILAMENTS; KERATINS; ONCOGENE PROTEINS, FUSION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS; VIRAL PROTEINS;

EID: 9144271383     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.2.821-833.2004     Document Type: Article

References (44)

1. Ashmole, I., P. H. Gallimore, and S. Roberts. 1998. Identification of conserved hydrophobic C-terminal residues of the human papillomavirus type 1 E1∧E4 protein necessary for E4 oligomerisation in vivo. Virology 240:221-231.
2. Bryan, J. T., K. H. Fife, and D. R. Brown. 1998. The intracellular expression pattern of the human papillomavirus type 11 E1∧E4 protein correlates with its ability to self associate. Virology 241:49-60.
3. Caulin, C., C. F. Ware, T. M. Magin, and R. G. Oshima. 2000. Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis. J. Cell Biol. 149:17-22.
4. Chou, C. F., C. L. Riopel, L. S. Rott, and M. B. Omary. 1993. A significant soluble keratin fraction in 'simple' epithelial cells. Lack of an apparent phosphorylation and glycosylation role in keratin solubility. J. Cell Sci. 105:433-444.
5. Chow, L. T., and T. R. Broker. 1994. Papillomavirus DNA replication. Intervirology 37:150-158.
6. Coulombe, P. A., and M. B. Omary. 2002. 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. Curr. Opin. Cell Biol. 14:110-122.
7. 2 arrest domain in the E1∧E4 protein of human papillomavirus type 16. J. Virol. 76:9806-9818.
8. de Villiers, E. M. 2001. Taxonomic classification of papillomaviruses. Papillomavirus Rep. 12:57-63.
9. Doorbar, J., R. Elston, S. Napthine, K. Raj, E. Medcalf, D. Jackson, N. Coleman, H. Griffin, P. Masterson, S. Stacey, Y. Mengitsu, and J. Dunlop. 2000. The E1∧E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus. J. Virol. 74:10081-10095.
10. Doorbar, J., S. Ely, N. Coleman, M. Hibma, D. H. Davies, and L. Crawford. 1992. Epitope-mapped monoclonal antibodies against the HPV16E1-E4 protein. Virology 187:353-359.
11. Doorbar, J., S. Ely, J. Sterling, C. McLean, and L. Crawford. 1991. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature 352:824-827.
12. Doorbar, J., C. Foo, N. Coleman, L. Medcalf, O. Hartley, T. Prospero, S. Napthine, J. Sterling, G. Winter, and H. Griffin. 1997. Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virology 238:40-52.
13. Doorbar, J., E. Medcalf, and S. Napthine. 1996. Analysis of HPV1 E4 complexes and their association with keratins in vivo. Virology 218:114-126.
14. Dyke, S. F., W. Williams, and J. T. Seto. 1978. Glycoproteins of representative paramyxoviruses: isolation and antigenic analysis using a zwitterionic surfactant. J. Med. Virol. 2:143-152.
15. Evans, R. M. 1998. Vimentin: the conundrum of the intermediate filament gene family. Bioessays 20:79-86.
16. Fuchs, E., and D. W. Cleveland. 1998. A structural scaffolding of intermediate filaments in health and disease. Science 279:514-519.
17. Fuchs, E., and K. Weber. 1994. Intermediate filaments: structure, dynamics, function, and disease. Annu. Rev. Biochem. 63:345-382.
18. Gilbert, S., A. Loranger, N. Daigle, and N. Marceau. 2001. Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation. J. Cell Biol. 154:763-773.
19. Inada, H., I. Izawa, M. Nishizawa, E. Fujita, T. Kiyono, T. Takahashi, T. Momoi, and M. Inagaki. 2001. Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD. J. Cell Biol. 155:415-426.
20. Ku, N. O., J. Liao, and M. B. Omary. 1998. Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. EMBO J. 17:1892-1906.
21. Ku, N. O., R. M. Soetikno, and M. B. Omary. 2003. Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury. Hepatology 37:1006-1014.
22. Liao, J., and M. B. Omary. 1996. 14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor. J. Cell Biol. 133:345-357.
23. Lowthert, L. A., N. O. Ku, J. Liao, P. A. Coulombe, and M. B. Omary. 1995. Empigen BB: a useful detergent for solubilization and biochemical analysis of keratins. Biochem. Biophys. Res. Commun. 206:370-379.
24. Lowy, D. R., and P. M. Howley. 2001. Papillomaviruses, p. 2231-2264. In P. M. Howley (ed.), Virology. Lippincott Williams and Wilkins, Philadelphia, Pa.
25. Middleton, K. 2003. Analysis of papillomavirus E1∧E4 expression with respect to epithelial proliferation and differentiation in productive and neoplastic papillomavirus lesions. Ph.D. thesis. University of London, London, United Kingdom.
26. Middleton, K., W. Peh, S. A. Southern, H. M. Griffin, K. Sotlar, T. Nakahara, A. El-Sherif, L. Morris, R. Seth, M. Hibma, D. Jenkins, P. F. Lambert, N. Coleman, and J. Doorbar. 2003. Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J. Virol. 77:10186-10201.
27. Moll, R., W. W. Franke, D. L. Schiller, B. Geiger, and R. Krepler. 1982. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24.
28. Munoz, N., and F. X. Bosch. 1997. Cervical cancer and human papillomavirus: epidemiological evidence and perspectives for prevention. Salud Publica Mex. 39:274-282.
29. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
30. Muslin, A. J., and H. Xing. 2000. 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal. 12:703-709.
31. Omary, M. B., N. O. Ku, J. Liao, and D. Price. 1998. Keratin modifications and solubility properties in epithelial cells and in vitro. Subcell. Biochem. 31:105-140.
32. Paramio, J. M., M. L. Casanova, C. Segrelles, S. Mittnacht, E. B. Lane, and J. L. Jorcano. 1999. Modulation of cell proliferation by cytokeratins K10 and K16. Mol. Cell. Biol. 19:3086-3094.
33. Paramio, J. M., S. Lain, C. Segrelles, E. B. Lane, and J. L Jorcano. 1998. Differential expression and functionally co-operative roles for the retinoblastoma family of proteins in epidermal differentiation. Oncogene 17:949-957.
34. Paramio, J. M., C. Segrelles, S. Ruiz, and J. L. Jorcano. 2001. Inhibition of protein kinase B (PKB) and PKCζ mediates keratin K10-induced cell cycle arrest. Mol. Cell. Biol. 21:7449-7459.
35. Peh, W. L., K. Middleton, N. Christensen, P. Nicholls, K. Egawa, K. Sotlar, J. Brandsma, A. Percival, J. Lewis, W. J. Liu, and J. Doorbar. 2002. Life cycle heterogeneity in animal models of human papillomavirus-associated disease. J. Virol. 76:10401-10416.
36. Pray, T. R., and L. A. Laimins. 1995. Differentiation-dependent expression of E1-E4 proteins in cell lines maintaining episomes of human papillomavirus type 31b. Virology 206:679-685.
37. Roberts, S., I. Ashmole, L. J. Gibson, S. M. Rookes, G. J. Barton, and P. H. Gallimore. 1994. Mutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells. J. Virol. 68:6432-6445.
38. Roberts, S., I. Ashmole, S. Rookes, and P. Gallimore. 1997. Mutational analysis of the human papillomavirus type 16 E1∧E4 protein shows that the C terminus is dispensable for keratin cytoskeleton association but is involved in inducing disruption of the keratin filaments. J. Virol. 71:3554-3562.
39. Roberts, S., M. L. Hillman, G. L. Knight, and P. H. Gallimore. 2003. The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts. J. Virol. 77:673-684.
40. Santos, M., C. Ballestin, R. Garcia-Martin, and J. L. Jorcano. 1997. Delays in malignant tumor development in transgenic mice by forced epidermal keratin 10 expression in mouse skin carcinomas. Mol. Carcinog. 20:3-9.
41. Southern, S. A., I. W. McDicken, and C. S. Herrington. 2000. Evidence for keratinocyte immortalization in high-grade squamous intraepithelial lesions of the cervix infected with high-risk human papillomaviruses. Lab. Investig. 80:539-544.
42. van Hemert, M. J., H. Y. Steensma, and G. P. van Heusden. 2001. 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays 23:936-946.
43. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
44. Walboomers, J. M., and C. J. Meijer. 1997. Do HPV-negative cervical carcinomas exist? J. Pathol. 181:253-254.